ArticleProceedings of the National Academy of Sciences of the United States of America2022
Targeting inflammation to improve regulatory T cell therapy for immunopathologies.
Benoit L SalomonPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.